|
December
headlines
Return
to December article index
Tests
to block blight of GE seed imports
December
20
New Zealand Herald
Border checks will be in place by March to test for
genetically engineered material in imported seed
shipments.
Until now there has been no compulsory testing of
imported seeds for GE contamination.
The New Zealand move comes at a time when there are no
international standards for quality assurance or border
tests.
New Zealand officials have just finished dealing with a
shipment of imported sweetcorn seed that was thought to
contain GE material.
Initial testing suggested there might be minute traces
of GE contamination, but a more detailed evaluation could
not detect any such material, said the Minister for the
Environment Marian Hobbs.
"Our best advice is that it is not possible to
establish a testing regime which would provide absolute
certainty that a batch of seed is GE-free."
She said achieving absolute certainty would require
every seed to be tested and the only way to eliminate the
risk would be to ban all seed imports from countries
growing GE crops.
She said the Government planned to allow a low level of
accidental contamination, such as 0.5 per cent in
shipments of maize and sweetcorn seed, using a test
sampling system.
These border checks will affect New Zealand's cropping
farmers, who import 186 tons of corn seed each year. About
161 tons of this comes from the United States, where some
farmers and grain handling companies have been found to
have been mixing conventional and GE corn crops.
New Zealand imports maize, sweetcorn, tomato, squash,
canola and a small amount of soybean seed from countries
that grow both GE and conventional seed.
Green Party co-leader Jeanette Fitzsimons said the
contamination scare came after a company with export
orders for GE-free corn tested its imported seed.
She said the order was an indication of a growing
market for food crop seeds from countries that did not
grow GE crops.
But Ms Hobbs said an outright ban on seed imports would
cost New Zealand farmers and horticulturists an estimated
$100 million a year.
It would also affect the extensive trade New Zealand
had in "bulking up" newly developed cultivars
for Northern Hemisphere companies wanting to get two crops
off the same seed line in one year.
This business, largely based in Canterbury, is
estimated to be worth $30 million a year.
Guidelines for New Zealand's sampling and testing
procedures are being developed by the Ministry of
Agriculture and Forestry and the Environmental Risk
Management Authority.
"We recognize this is a conservative approach and
we will be looking to the Royal Commission [on Genetic
Modification] for advice in its findings on how such
issues should be treated in the future," said Ms
Hobbs.
The interim standards are to be established by March,
which is when orders for the next growing season are
expected.
Ms Hobbs said the standards could be reviewed if any
changes were needed after the royal commission reported in
June.
Government
to promote biotech in farm, food sectors
December 19
Times of India
NEW DELHI - The government will soon take several steps
to popularize the use of biotechnology in the agriculture
and food processing sectors. It will also establish ``more
functional biotechnology parks'' to trigger a revolution in
biotech industries, Union HRD and science minister Murli
Manohar Joshi said on Monday.
Joshi, while inaugurating a three-day national conference
on ``Emerging trends in biopharmaceuticals, proteins and the
role of chromatography'', stressed the urgent need to
promote the concept of biotechnology to meet international
standards of food safety and industrial production.
The biotech industry's key objective should be to develop
widely-applicable, easily and adequately scaled up,
reproducible and cost-effective processes and products,
especially in agriculture, biopesticides, fertilizers and
health care and industrial enzymes, he said.
The government will also strengthen the existing R&D
facilities and open training centers and laboratories to
help in implementation and adoption of biotechnology
products, especially by the small-scale sector and
agro-rural industry, he said.
The minister said since the demand for food processed
with the help of biotechnology was on the increase globally,
the increased use of biotech by various industries would
lead to greater quality production and exports.
Exhorting the private sector to play a greater role in
this field, Joshi said Better cooperation with the public
sector can end unnecessary problems in biotechnology-based
industries in the country.
StarLink
find fuels fresh U.S. uncertainty
December 19
Reuters
Chicago - The discovery of unapproved gene-altered
StarLink corn in Japan and South Korea, top buyers of
American corn, has triggered fresh uncertainty in U.S. corn
exports, industry sources said on Tuesday.
The detection comes at a time when imports of U.S. corn
by the two nations were expected to return to normal pace
after a sharp decline in recent months due to concerns over
StarLink.
StarLink corn, originally developed to be resistant to
the European corn borer insect pest, is not approved for
food use in the United State because of concerns it might
trigger allergic reactions. But it is allowed as animal
feed.
Japan, the top market for U.S. corn, does not allow
StarLink corn for use in either food or feed, while South
Korea permits the genetically-modified corn only for feed
purposes.
The National Corn Growers Association on Tuesday did not
rule out the possibility of its officials making trips to
the two Asian countries to calm nerves.
``It shouldn't have happened,'' NCGA spokesman Stewart
Reeve said. ``It's a major concern ... and as any good
salesman does, we are willing to make those customer visits.
A possibility of a trip (to Japan and South Korea) certainly
exists.''
Analyst Shawn McCambridge of Prudential Securities said
under Japan's zero tolerance policy on StarLink corn, even
trace amounts of the corn would disqualify shipments.
"In my view, the U.S. is doing about everything humanly
possible, to do anything more will be extremely difficult at
this point.
"If we had something along the lines of 2 to 4
percent tolerance, it would definitely be much easier to
accomplish.
``The discovery will shake the confidence of the trade.
The trade yesterday found that maybe we had most of the
problems behind us. The ink's barely dry on the agreement
and all of a sudden we are having problems again,'' he
added.
On Monday, Japan and the United States reached agreement
on StarLink testing procedures, raising optimism among
traders that Japan's imports of U.S. corn would return to
normal.
Japan's Kyodo news agency reported on Tuesday the Health
Ministry found StarLink corn in a cargo of U.S. corn for
food use. Kyodo said the sample containing StarLink was
among five that had tested negative in the United States but
were sent to Japan for a second check under a bilateral
agreement.
The Korea Food and Drug Administration said it had
detected StarLink corn in a shipment from the United States
and that the 2,760 tons would be used for industrial or feed
purposes. It said the suppliers were Cargill Inc. and Agrex
Inc.
A spokesman for privately-held agricultural powerhouse
Cargill Inc. said the company was checking to verify the
``facts of the case'' in South Korea. He declined further
comment.
StarLink corn, developed by European pharmaceutical giant
Aventis SA , was first detected in U.S. food products in
September. That lead to a series of food recalls.
Aventis CropScience, the U.S. unit of Aventis, has since
been buying StarLink corn at a premium to ensure the corn is
kept out of the food chain. Grain companies have been
testing corn arriving at their facilities and heading for
export markets for traces of StarLink.
A spokeswoman for Aventis CropScience said: ``We are
working with exporters and grain handlers on a case-by-case
basis to cover incremental costs associated with moving
StarLink corn to correct uses.'' She declined to elaborate.
A spokesman for agribusiness giant Archer Daniels Midland
Co said the company was not the supplier of the
StarLink-tainted corn to Japan. He also said it was too
early to say if the detection would affect U.S. corn
exports.
``I still think that at the end of the day, we got to
find ways to work together to assure them that they are
getting the kind of products they want,'' spokesman Larry
Cunningham said.
Exporters said the latest discovery of StarLink corn is
expected to dent corn exports to Japan, which imports 4
million tons of corn for food and another 12 million tons
for animal feed a year.
They said that Japan could decide to source more of its
corn from South America, where corn planted this year will
become available for export shipments from April 2001.
Brazil's 2000/01 corn production has been officially
forecast at 38.49 million tons, up 21.67 percent from the
previous year.
StarLink found
in U.S. corn set for Japan food use
December 19
Reuters
Japan's Health Ministry has found genetically modified
StarLink corn, banned by Tokyo, in a cargo of corn for food
use awaiting shipment to Japan from the United States, the
Kyodo news agency said on Tuesday.
The announcement came just a day after Japan's
Agriculture Ministry said it had agreed to a U.S. plan for
testing corn to be shipped to Japan for animal feed to
ensure it does not contain StarLink gene-spliced corn.
Japan, the single biggest buyer of U.S. corn, has cut
purchases sharply since a consumer group in late October
found traces of StarLink in Japan's food and feed products
made from U.S.-imported corn.
Kyodo said the sample containing StarLink was among five
that had tested negative in the United States but were sent
to Japan for a second check under an agreed procedure
between the two countries,
The ministry has asked the U.S. government to halt the
shipment of the 1,500 tons of the corn from which the sample
was taken.
The finding could be a blow to U.S. exporters after
traders said Monday's agreement on the plan for genetic
testing to detect StarLink biotech corn in exports for
animal feed would likely spur Japanese buying of U.S. corn
this week.
The Agriculture Ministry said on Monday it and the U.S.
Department of Agriculture (USDA) would support exporters and
importers seeking compensation from Aventis CropScience, the
developer of StarLink corn, for the cost of supplying
information and other expenses associated with the
certification process.
Japan's Health Ministry agreed in November to a USDA plan
to prevent StarLink from being mixed with food exports to
Japan.
Japan imports four million tons for food and another 12
million tons for animal feed each year. StarLink is not
approved for use in either food or animal feed in Japan.
StarLink, made by Franco-German drug firm Aventis SA ,
has not been approved by U.S. regulators for human
consumption because of potential allergic reactions.
U.S.
exports not hurt by StarLink incidents - embassies
December 19
Reuters
Japanese and South Korean diplomats said on Tuesday the
discovery of StarLink bio-corn in cargoes destined for their
countries' food and animal feed supply would not impact
future U.S. corn exports.
Two separate U.S. corn shipments destined for Japan's
food supply and South Korea's animal feed industry were
found on Tuesday to be tainted with the genetically-altered
StarLink corn.
Masaki Sakai, Japanese counselor for agriculture to the
United States, said the world's biggest buyer of American
corn had no intention of reneging on a U.S. trade agreement
it approved earlier this week because of the incident.
Japan's Agriculture Ministry on Monday agreed to expand a
U.S. plan, or protocol, for testing shipments of corn for
animal feed to ensure they do not contain StarLink bio-corn.
The original agreement, approved last month, applied only to
U.S. corn exports bound for Japan for human consumption.
``We don't have to change the protocol system because of
this happening,'' Masaki Sakai, Japanese counselor for
agriculture to the United States, told Reuters. ``The double
check is already incorporated in the system.''
Sakai said the Japanese government was ``expecting this
kind of thing'' and had taken extra precautions when
agreeing to the U.S. plan for StarLink testing.
Under the U.S.-Japan agreement, the Japanese government
would conduct random tests on arriving shipments to confirm
they are free of StarLink.
Sakai said the sample containing StarLink found on
Tuesday was among five that had tested negative in the
United States but were sent to Japan for a second check. The
ministry has asked the U.S. government to halt the shipment
of the 1,500 tons of the corn from which the sample was
taken.
``I hope this kind of thing won't be happening very often
in the future,'' Sakai said. ``But there is no intention to
change the system.''
Japanese importers sharply cut back purchases in recent
weeks due to concerns that shipments might be contaminated
with StarLink, a corn variety made by Aventis SA that is
genetically modified to repel pests.
Japan imports 4 million tons for food and another 12
million tons for animal feed each year. StarLink is not
approved for use in either food or animal feed in Japan.
No problems for
U.S. corn in South Korea
The Korea Food and Drug Administration (KFDA) on Tuesday
detected the StarLink variety in a U.S. corn shipment of
2,760 tons.
KFDA said the corn shipment from Agrix Inc. and Cargill
Inc. was only for industrial or feed purposes, not for human
consumption.
``There is no problem,'' Soo Hwa Lee, South Korean
counselor of agriculture to the United States, told Reuters.
``This shipment was for animal feed, not for food use.''
Lee said he would meet with USDA officials sometime this
week to discuss the incident.
USDA officials said a StarLink testing agreement similar
to Japan's protocol should be completed and finalized soon.
South Korea imports almost two million tons of corn per
year for human consumption, mostly from the United States.
U.S. regulators banned StarLink from human consumption in
1998 due to concerns it might cause allergic reactions.
Study
validates safety of Bt crops
December 18
AgWeb.com
Yet another study supports previous evidence that Bt
(Bacillus thuringienisis) crops are just as safe as
conventional plant varieties, and because they provide
protection against insects, they also provide significant
benefits. However, the study was carried out by Monsanto, a
seed company known for its Bt products.
The study appears in the peer-reviewed scientific
journal, Regulatory Toxicology and Pharmacology. The
evaluation process involved reviewing data on three major Bt
crops -- corn, cotton and potatoes -- that have been
commercialized in several countries. Bt crops have been
available since 1996.
"The combined safety and performance studies,
combined with years of experience, have shown that Bt crops
are providing important benefits on many different
levels," said Dr. Roy Fuchs, director of regulatory
science at Monsanto Company, a coauthor of the paper.
The most significant benefits of Bt crops include reduced
use of synthetic chemical insecticides, the study pointed
out. Bt crops contain a gene that produces a naturally
occurring protein that protects plants from specific insect
pests and provides a level of insect protection generally
superior to conventional chemical insecticides. As a result,
Bt crops require fewer applications of chemical
insecticides, thereby significantly reducing the overall
amount of chemical used on food, feed and fiber crops.
For 1998, the National Center for Food and Agricultural
Policy (NCFAP) estimated that 2 million fewer pounds of
chemical insecticides were used to control cotton bollworms
and budworms in six key cotton-producing states, compared to
the insecticide levels used prior to the introduction of Bt
cotton.
The study also found that Bt crop protection against
insect damage translates to significant yield increases. In
1997, a year with a heavy infestation of the European corn
borer in the United States, NCFAP reported that Bt corn
provided a yield premium of almost 12 bushels per acre over
conventional corn varieties. The same researchers estimated
that the use of Bt cotton in the United States in 1998
resulted in an increased fiber yield of 85 million pounds.
In the United States, where commodity prices are at the
lowest levels in decades, Bt crops reduce the total amount
of input costs for farming, which translates to direct
economic benefits to farmers, the study stated.
NCFAP estimated that in 1998 alone Bt cotton created
approximately $92 million in value for U.S. cotton growers.
Protection
of crops given new approach
December 18
The Scotsman
A FRESH approach to crop protection technology was
unveiled by one of the biggest multinationals in the field
yesterday.
This is aimed at linking the demands of the end user -
processor, retailer or consumer - with the agronomic needs
of the primary producer.
It will bring together specific crop treatments, including
an enhanced biological control approach, with highly customized
seeds and in time a strong biotechnology, or genetically
modified, bias.
This is in spite of what Stephen Smith, head of Syngenta
Seeds UK, described as "the regulatory
constipation" of the European authorities in approving
new developments.
The seed company is part of the $7 billion a year Syngenta
group which emerged earlier this year from the merger of
Novartis Agribusiness and Zeneca Agrochemicals, putting it
among the top three players in terms of share of the $40
billion global crop protection and seeds market.
In London yesterday, Jan Suler, who heads up the UK and
Ireland crop protection business, outlined a holistic
approach to food production which would provide advantages
for growers, processors, retailers, consumers and the
environment.
To help it achieve this the company will be investing around
$800 million a year in research and development, with about
20 per cent of this going into GM crop development. At the
same time a large sum of money was being invested in its
Bioline company which produces beneficial insects and mites
to tackle the biological control market.
This fitted into the company’s philosophy of integrated
crop management, linking more desirable seed traits with
lower chemical usage, and farmer support in decision making.
Mad
Cow reality confronts phony biotech scare
December 18
Tech Central Station column by Duane D. Freese
Have Greenpeace protesters
finally thrown up one barricade too many against
biotechnology and the benefits it offers?
In what at first looks like nothing unusual from an
organization noted for its catchy name-calling and
confrontational theatrics, Italian Greenpeace activists last
week held up a ship carrying genetically modified (GM)
soybeans headed for Venice to feed Europe's livestock. The
same day in Montpelier, France, outside an international
conference, drawing up rules for biotechnology trade,
another set of protestors dumped tons of GM soy meal onto a
U.S. flag.
The purpose of these escapades supposedly was to awaken
European officials to the dangers, as seen by Greenpeace, of
feeding even livestock genetically modified food. “Farmers
don’t know what they are feeding their animals,”
explained Lorenz Petersen, head of Greenpeace’s global
anti-GM campaign.
Instead of GM's dangers, though, these activities offer a
wake-up call about Greenpeace as a threat to health. For the
day after Greenpeace spread its phony fears about imports of
GM soybeans, the British science weekly Nature warned of
something truly frightening. The report, by epidemiologist
Christi Donnelly of London's Imperial College School of
Medicine, found that as many as 9,800 French cattle had
become infected with bovine spongiform encephalopathy,
commonly known as mad-cow disease. Worse, still, some of
their meat has entered the human food chain.
In the 1990s, Britain suffered an epidemic of mad-cow
disease, which led to at least 77 people who ate the meat
dying of a human variant, the brain-eating Creutzfeldt-Jakob
Disease. Last month, the shockwave hit the continent when
France reported two of its citizens had died from that
affliction, while Germany found cattle there infected with
mad-cow disease, as well. How many people now are infected
is unknown, as the disease is impossible to diagnose until
symptoms of dementia emerge, and that can take up to 25
years. The numbers could climb into the hundreds, possibly
even thousands.
Little wonder then that people in Europe are panicked,
afraid to eat their own beef. Meat sales have fallen by half
in the last month. And governments for nations where herds
have yet to be found infected have thrown up barriers to
meat and livestock imports from their neighbors.
Smart Europeans now may start asking why they have a problem
with their beef while the United States does not. The reason
is simple. European farmers followed a “natural” way of
adding protein to the diets of their cows, feeding them bone
meal and meat byproducts. And that’s how the disease
appears to have spread. Britain’s cattle, scientists there
believe, picked up mad-cow disease from the bone meal and
meat from slaughtered sheep infected with a related disease,
scrapie.
American cattle, meanwhile, feed on grain supplemented by
protein from soy meal. That’s no surprise, as the United
States is the source of nearly half the soybean production
in the world. And since the1996 introduction of Monsanto’s
Roundup Ready soy beans – genetically modified to make it
tolerant to a more environmentally friendly herbicide –
crossbreeding and additional genetic modification has led to
more than half the soy crop having some genetic
modification.
Those GM crops are demonstrably as safe or even safer than
conventional crops. As the U.S. House subcommittee on Basic
Research noted in a report last April: “No product of
conventional plant breeding … could meet the data
requirements imposed on biotechnology products by U.S.
regulatory agencies.”
Until now, that fact has been lost on Europeans, who’ve
instead bought Greenpeace’s scientifically unsubstantiated
line that so-called natural breeding and feeding is best for
the environment and health.
Greenpeace was helped in spreading that propaganda by both
Europe’s politically powerful, heavily subsidized farmers
and politicians, who wanted to shift the cost of those
subsidies off government budgets onto European consumers.
Last year, the European Parliament ordered food producers to
label GM products as if they posed some added risk to
consumers, which they don’t. European food processors
succumbed, vowing not to use any GM ingredients on products
for human consumption, with American competitors following
suit. The French government went so far as to ban planting
GM soybeans there altogether.
This GM backlash by supposedly advanced nations has undercut
investment in biotechnology, to the particular detriment of
people in poorer countries. Developing lands stand to
benefit most from crops genetically modified to resist
drought or increase protein and vitamin potency. One GM crop
alone, vitamin-A enhanced golden rice holds the promise of
preventing blindness for up to 3 million malnourished poor
children.
Now, it's Europe's health and economic well-being that is
threatened by Greenpeace's anti-technology agenda. France's
$20 billion beef industry faces a mad-cow meltdown. European
farmers need 3 million tons of high-protein soy meal to
replace that provided by potentially deadly meat by-products
-- but most of the soybean supply is likely to have been
genetically modified. And both Europeans and people
elsewhere in the world need tools that only biotechnology
can provide to screen meat and blood for safety.
Indeed, Americans face a threat to their blood supply if
Europe fails to get a handle on its mad-cow epidemic. People
needing transfusions might pick up Creutzfeldt-Jakob Disease
from tainted blood donated by travelers infected on trips to
Europe. The Food and Drug Administration is weighing a blood
ban for donations from people who have spent more than six
months in Britain, a costly measure with blood in short
supply.
Fortunately, biotechnology may provide an answer here, as
well. Last month, the biotech firm Prion Developmental
Laboratories, Inc., of Maryland began development of an
effective and inexpensive screening test to detect mad-cow
disease and its human variant. Heading the research is Dr.
Robert Gallo, professor of virology at the University of
Maryland and director of the Institute of Human Virology.
Working with him in this substantially privately funded
effort are noted scientific researchers at Case Western
Reserve in Cleveland, Ohio, and from the Institute for Basic
Research and Developmental Disabilities in Staten Island,
N.Y.
It’s time Europeans wake up to the benefits that
biotechnology has to offer. Following Greenpeace’s lead of
dumping on the American flag and biotechnology will only
lead them down the same path as the 4.5 million cattle that
the mad-cow epidemic has thus far forced them to slaughter.
Scientists
invent glowing potato
December 18
Agence France Presse
Scientists in Scotland claimed Monday to
have invented a genetically-modified potato which glows
bright green to let the farmer know when it needs watering.
The team of researchers from the
University of Edinburgh claim their invention will help make
better use of limited water supplies in developing
countries.
It will also increase crop yields by
giving an early warning when the plants do not have enough
water, the most common cause of disappointing harvests.
The scientists, led by Antony Trewavas,
introduced a fluorescent gene from a jellyfish into the
leaves of the potato plant.
When the plant becomes dehydrated, a
protein is formed within the plant which triggers the gene,
making it glow. This cannot be seen by the naked eye, but is
visible using a hand held monitor.
The glowing plants will prove useful to
farmers because, "in the long term, in 40 years or so,
water will be the most expensive agricultural
commodity," Trewavas said.
He added that only a few of the
genetically-modified plants need to be planted in the crop
to gauge whether there is enough water.
They can be removed before harvesting if
there is any concern among consumers about eating modified
potatoes, and because they are tubers they will not
cross-fertilize with the rest of the crop, he claimed.
|